NA
ABVX

NewEdge Advisors’s Abivax ABVX Stock Holding History

NewEdge Advisors’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.27K Sell
17
-137
-89% -$15.5K ﹤0.01% 3890
2026
Q1 		$17.1K Hold
154
– – ﹤0.01% 3241
2025
Q4 		$20.8K Buy
+154
New +$16.8K ﹤0.01% 3243
2025
Q3 		– Sell
-30,000
Closed -$230K – 4095
2025
Q2 		$230K Buy
+30,000
New +$196K ﹤0.01% 2152

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NewEdge Advisors's ABVX Position: Q2 2026 in Review

NewEdge Advisors reduced its Abivax (ABVX) stake by 89% in Q2 2026, selling an estimated $15.5K and leaving 17 shares worth $2.27K. The position accounts for ﹤0.01% of the portfolio, ranked #3890.

NewEdge Advisors first reported a position in ABVX in Q2 2025 and has held it in 4 quarters since. The position peaked at $230K in Q2 2025. 302 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • NewEdge Advisors held 17 shares of Abivax worth $2.27K as of Q2 2026.
  • NewEdge Advisors sold 137 Abivax shares in Q2 2026, an estimated $15.5K.
  • Abivax made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #3890 holding.
  • NewEdge Advisors first reported a position in Abivax in Q2 2025 and has held it in 4 quarters since.
  • NewEdge Advisors's Abivax position peaked at $230K in Q2 2025.
  • 302 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.